Document Detail


Enalaprilat, an intravenous angiotensin-converting enzyme inhibitor, in hypertensive crises.
MedLine Citation:
PMID:  2990798     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of enalaprilat (MK-422), a newly synthesized, intravenous, nonsulfhydryl, angiotensin-converting enzyme inhibitor, was studied in seven patients with either severe or malignant hypertension. All subjects initially received a 1 mg bolus injection of enalaprilat followed in 30 minutes by 10 mg. Five subjects received an additional 40 mg. Mean (+/- SE) pretreatment blood pressure for the group was 226 +/- 9/141 +/- 7 mm Hg. Five minutes after the 1 mg enalaprilat dose, blood pressure decreased to 211 +/- 10/131 +/- 9 mm Hg and further fell to 201 +/- 14/123 +/- 11 mm Hg at 30 minutes. The maximal reduction in blood pressure to 169 +/- 14/112 +/- 10 mm Hg occurred 30 minutes after the 10 mg dose. No further blood pressure reduction was observed in those subjects who received the additional 40 mg dose. Within the entire group, five subjects exhibited sustained blood pressure reduction. No adverse side effects or symptomatic hypotension occurred in any subject.
Authors:
D J DiPette; J C Ferraro; R R Evans; M Martin
Related Documents :
2056908 - Effect of exercise training on blood pressure in 70- to 79-yr-old men and women.
11302898 - Changes in blood pressure among students attending glasgow university between 1948 and ...
18617068 - Sodium nitroprusside for advanced low-output heart failure.
8636558 - Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after ...
3338308 - Effect of pulmonary vascular pressure on lung lymph flow following seizures.
24266478 - Orientation relations during the α-ω phase transition of zirconium: in situ texture ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical pharmacology and therapeutics     Volume:  38     ISSN:  0009-9236     ISO Abbreviation:  Clin. Pharmacol. Ther.     Publication Date:  1985 Aug 
Date Detail:
Created Date:  1985-09-11     Completed Date:  1985-09-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372741     Medline TA:  Clin Pharmacol Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  199-204     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Angiotensin-Converting Enzyme Inhibitors*
Antihypertensive Agents*
Dipeptides / administration & dosage,  therapeutic use*
Emergencies
Enalaprilat
Female
Heart Rate / drug effects
Humans
Hypertension / drug therapy*
Injections, Intravenous
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Dipeptides; 84680-54-6/Enalaprilat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Indium-111 chloride for detecting suspected hepatomas in patients with focal defects on technetium-9...
Next Document:  The value of angiotensin-I-converting enzyme determinations in malignant and other diseases.